3SBio Inc.: all 106 studies

Page 1 of 2. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.

• SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung CancerNot yet recruitingNCT07874984Phase 2
• Phase I Clinical Study to Evaluate the Safety and Efficacy of 3SC009 Monotherapy for Patients With Advanced Solid TumorsNot yet recruitingNCT07815002Phase 1
• Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)RecruitingNCT07767253Phase 3
• A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerRecruitingNCT07757230Phase 2
• A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering TreatmentNot yet recruitingNCT07708181Phase 2
• A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic DermatitisRecruitingNCT07693738Phase 1
• SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07646626Phase 2
• A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult ParticipantsNot yet recruitingNCT07606976Phase 1
• The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UCRecruitingNCT07507513Phase 2
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous InfusionNot yet recruitingNCT07487545Phase 1
• 1% Clascoterone Cream for the Treatment Acne VulgarisNot yet recruitingNCT07457294Phase 3
• The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.Not yet recruitingNCT07445308Phase 1/2
• A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)Not yet recruitingNCT07349329Phase 3
• A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)RecruitingNCT07261644Phase 3
• A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal CancersNot yet recruitingNCT07233850Phase 2
• The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLERecruitingNCT07185269Phase 1/2
• A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） PatientsRecruitingNCT07171606Phase 2
• Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic AlopeciaRecruitingNCT07080931Phase 3
• Evaluation of 627 in Healthy Adult SubjectsNot yet recruitingNCT07065136Phase 1
• Safety, Tolerability, PK and PD of SSS55 in Healthy SubjectsRecruitingNCT07058779Phase 1
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese SubjectsEnrolling by invitationNCT07057726Phase 1
• Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic DermatitisRecruitingNCT07042126Phase 3
• A Study of Two Different Formulations of 611 in Healthy Adult Subjects in ChinaNot yet recruitingNCT07042113Phase 1
• Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07039669Phase 3
• A Phase I Study of SPGL008 in Subjects With Advanced Malignant TumorsRecruitingNCT07038005Phase 1
• A Phase I Study of SSGJ-612 in Patients With Advanced Solid TumorsRecruitingNCT07032298Phase 1
• A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese MalesNot yet recruitingNCT07025915Phase 1
• SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07022002Phase 2
• A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant TumorsRecruitingNCT07016490Phase 1
• Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer PainRecruitingNCT07008703Phase 1/2
• Phase IIa Trial of Oral SSS17 for Post-Arthroplasty AnemiaNot yet recruitingNCT07007936Phase 2
• Phase I Study of HBT-708 for Patients With Advanced Solid TumorsRecruitingNCT06993870Phase 1
• SSGJ-707 in Advanced Non-Small Cell Lung CancerRecruitingNCT06980272Phase 3
• A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant TumorsRecruitingNCT06944444Phase 1
• Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid MalignanciesNot yet recruitingNCT06854276Phase 2
• Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 1
• A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer PatientsRecruitingNCT06522828Phase 2
• A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer PatientsRecruitingNCT06493760Phase 2
• A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC PatientsRecruitingNCT06412471Phase 2
• Efficacy and Safety of Clascoterone Cream 1% in Facial Acne VulgarisRecruitingNCT06403501Phase 3
• A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant TumorsRecruitingNCT06390774Phase 1
• A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC PatientsRecruitingNCT06361927Phase 2
• Efficacy and Safety Study of 610 in Patients With Severe AsthmaRecruitingNCT06323213Phase 3
• An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsONot yet recruitingNCT06299982Phase 3
• A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)RecruitingNCT06222671Phase 2
• A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutNot yet recruitingNCT06169891Phase 3
• The MAD Study of SSGJ-613 in Healthy SubjectsNot yet recruitingNCT05966701Phase 1
• A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy SubjectsCompletedNCT07024888Phase 1
• Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKDCompletedNCT07014631Phase 2
• A Phase IIb Study of 610 in Participants With Severe Eosinophilic AsthmaActive, not recruitingNCT06680947Phase 2
• Evaluation of 626 in Healthy Adult SubjectsCompletedNCT06674525Phase 1
• A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT06639295Phase 3
• Phase I Study to Evaluate rhTPO in Healthy Caucasian VolunteersCompletedNCT06630494Phase 1
• Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic DermatitisCompletedNCT06554847Phase 3
• Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid TumorsStatus unknownNCT06533605Phase 1
• Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult SubjectsCompletedNCT06454708Phase 1
• Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic DermatitisCompletedNCT06324812Phase 1/2
• A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.Active, not recruitingNCT06270225Phase 2
• A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)Active, not recruitingNCT06242652Phase 2
• Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic DermatitisCompletedNCT06173284Phase 3
• Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT06099652Phase 2
• A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT05865496Phase 2
• Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05641558Phase 1/2
• A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque PsoriasisStatus unknownNCT05604898Phase 2
• A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutStatus unknownNCT05588908Phase 1/2
• A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic AsthmaStatus unknownNCT05584306Phase 1
• Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic DermatitisCompletedNCT05544591Phase 2
• A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT05536726Phase 3
• A Phase II Study of 610 in Participants With Severe Eosinophilic AsthmaStatus unknownNCT05528679Phase 2
• A Phase III Study for 601 Versus Ranibizumab in Patients With Vision LossCompletedNCT05520177Phase 3
• Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal FailureStatus unknownNCT05211167Phase 3
• A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic SarcomaStatus unknownNCT05193214Phase 2
• A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseStatus unknownNCT05193201Phase 1
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid TumorsStatus unknownNCT05145179Phase 1
• A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue SarcomaStatus unknownNCT05138146Phase 2
• Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody InjectionStatus unknownNCT05027373Phase 1
• 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)Status unknownNCT04922151Phase 2
• A Phase 1 Study of SSS17 in Healthy Subjects.Status unknownNCT04893187Phase 1
• A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating TabletStatus unknownNCT04728984Phase 3
• 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT04667910Phase 2
• 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT04667897Phase 2
• Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy VolunteersCompletedNCT04527718Phase 1
• The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)Status unknownNCT04468997Phase 1
• Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal CancerStatus unknownNCT04466254Phase 2
• Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody InjectionStatus unknownNCT04445038Phase 1
• Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy SubjectsStatus unknownNCT04367441Phase 1
• Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing SpondylitisCompletedNCT04345458Phase 3
• A Study of SSS17 in Healthy SubjectsStatus unknownNCT04317833Phase 1
• The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)Status unknownNCT04151407Phase 1
• Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)CompletedNCT04089267Phase 4
• A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult VolunteersStatus unknownNCT04047394Phase 1
• Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in ChinaStatus unknownNCT03998345Not applicable
• Pharmacokinetics, Efficacy and Safety of the 304 InjectionStatus unknownNCT03980379Phase 1
• Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With HemodialysisStatus unknownNCT03950687Phase 2
• Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609AStatus unknownNCT03950297Phase 1
• The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function ImpairmentStatus unknownNCT03673215Early Phase 1
• A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.Status unknownNCT03388515Phase 1
• A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal CancerStatus unknownNCT03356158Phase 1
• Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)CompletedNCT02947438Phase 3
• Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)TerminatedNCT02522975Phase 4

← 3SBio Inc. overview and focus areas